1.
Montagna M, Montillo M, Avanzini MA, Tinelli C, Tedeschi A, Visai L, Ricci F, Vismara E, Morra E, Regazzi M. Relationship between pharmacokinetic profile of subcutaneously administered alemtuzumab and clinical response in patients with chronic lymphocytic leukemia. Haematologica [Internet]. 2011Jun.1 [cited 2026Nov.1];96(6):932-6. Available from: https://haematologica.org/article/view/6003